Ezaki Glico (2206) FY2026 Q2 Earnings Report

Quick View

Executive Summary

Revenue and earnings increased, mainly driven by growth in the overseas business, although the consolidated operating margin remained at a low level. Revenue was 1803.7B yen (+9.7% YoY), Operating Income was 46.5B yen (+42.8%), Ordinary Income was 72.2B yen (+31.1%), and Net Income was 50.0B yen (+32.7%). The operating income growth rate exceeding the revenue growth rate indicates that gross profit expansion absorbed the increase in SG&A expenses; however, the 2.6% operating margin, although improved from approximately 2.0% in the previous year, remains below the general profitability benchmark of 5%.

Factors Affecting Results

【Revenue】Revenue was 1803.7B yen (+9.7% YoY). By segment, the Overseas Business posted the strongest growth at 540.6B yen (+32.3%), raising its revenue composition ratio to 30.0%. The Dairy Business at 321.8B yen (+4.9%), Nutrition Confectionery Business at 299.2B yen (+0.2%), Domestic Other Businesses at 401.9B yen (+0.6%), and Health & Food Business at 211.9B yen (+2.1%) posted only modest increases, while the Food Ingredients Business declined by 1.7% to 64.2B yen.

【Profit and Loss】The 42.8% increase in Operating Income to 46.5B yen was primarily driven by the Overseas Business, which generated segment income of 75.8B yen (+66.1%, margin of 14.0%). Meanwhile, the Dairy Business continued to report an operating loss of ▲41.7B yen, and the Health & Food Business also recorded a loss of ▲14.4B yen. Non-operating income of 35.3B yen (including dividend income of 4.7B yen and foreign exchange gains of 3.1B yen) boosted Ordinary Income, which increased to 72.2B yen (+31.1%). Extraordinary income of 5.4B yen included a gain on the sale of investment securities of 5.0B yen and should be distinguished as a temporary factor. Net Income was 50.0B yen (+32.7%). In conclusion, the Company achieved higher revenue and earnings amid the coexistence of high growth in the Overseas Business and unprofitable domestic businesses.

Segment Analysis

The Overseas Business was the primary driver of consolidated earnings, with revenue of 540.6B yen (+32.3% YoY) and segment income of 75.8B yen (+66.1%, margin of 14.0%). The Food Ingredients Business generated revenue of 64.2B yen (▲1.7%) but achieved segment income of 12.2B yen (+23.6%) and a high margin of 19.0%, although its scale was small. The Dairy Business continued to report a segment loss of ▲41.7B yen against revenue of 321.8B yen (+4.9%), while the Health & Food Business posted a loss of ▲14.4B yen against revenue of 211.9B yen (+2.1%). The Nutrition Confectionery Business was nearly flat, with revenue of 299.2B yen (+0.2%), but segment income declined significantly to 9.7B yen (▲51.2%), reducing its margin to 3.2%. The Domestic Other Businesses generated revenue of 401.9B yen (+0.6%) and income of 1.4B yen (▲43.7%). The contrast between high-margin growth in the Overseas Business and continued losses in the Dairy and Health & Food Businesses is pronounced.

Key Financial Metrics

【Profitability】The operating margin was 2.6%, improving from approximately 2.0% in the same period of the previous year, but remaining below 5%. The net profit margin was 2.8%, while the gross margin was 37.1%, a sound level for the food and beverage industry.【Cash Flow Quality】Non-operating income of 35.3B yen was equivalent to 75.9% of Operating Income, with non-business-related income such as dividend income of 4.7B yen and foreign exchange gains of 3.1B yen boosting Ordinary Income. Of the 5.4B yen in extraordinary income, 5.0B yen was a gain on the sale of investment securities and should be distinguished as a non-recurring element.【Investment Efficiency】ROE was 1.8%, indicating limited income-generating capacity from Operating Income of 46.5B yen relative to the substantial asset base of 61.48B yen in investment securities and 68.09B yen in cash and deposits.【Financial Soundness】The Equity Ratio was a robust 70.1%, and current assets of 172.33B yen substantially exceeded current liabilities of 94.94B yen. While long-term borrowings were minimal at 0.1B yen, short-term borrowings of 17.14B yen accounted for most interest-bearing debt, indicating dependence on short-term funding.

Cash Flow Analysis

As cash flow statement figures were not included in the disclosed data, funding trends are analyzed based on changes in the balance sheet. Cash and deposits were 68.09B yen, remaining almost flat compared with 68.63B yen at the end of the same period of the previous year. Total assets were 386.62B yen, down 7.51B yen from the previous year, while net assets also declined by 7.68B yen to 270.85B yen. Treasury stock increased significantly to 26.98B yen from 13.60B yen in the same period of the previous year, suggesting that share repurchases were one factor behind the decline in net assets. Short-term borrowings increased substantially to 17.14B yen from 0.05B yen in the same period of the previous year, potentially reflecting funding for working capital or share repurchases. On-hand liquidity remained ample, with cash and deposits of 68.09B yen equivalent to 3.97 times short-term borrowings, indicating that financial flexibility was maintained.

Earnings Quality

Of Ordinary Income of 72.2B yen, Operating Income accounted for only 46.5B yen, with the remaining 25.6B yen dependent on net non-operating income (non-operating income of 35.3B yen - expenses of 9.7B yen). Non-operating income included dividend income of 4.7B yen, interest income of 3.6B yen, and foreign exchange gains of 3.1B yen, indicating that income with limited business relevance boosted Ordinary Income. In addition, profit before taxes of 77.6B yen included extraordinary income of 5.4B yen (including a 5.0B yen gain on the sale of investment securities), which should be distinguished from the recurring earning power of the core business as a temporary factor. Profit before taxes excluding extraordinary income was approximately 72.2B yen, nearly in line with Ordinary Income. Comprehensive income was 89.0B yen, exceeding Net Income of 50.0B yen. The difference was primarily attributable to valuation differences on securities of 26.6B yen and foreign currency translation adjustments of 17.8B yen. These are variable elements associated with market fluctuations and should be distinguished when assessing earnings quality.

Earnings Forecasts and Guidance

The Q2 progress rates against the full-year forecasts were 46.2% for Revenue (forecast of 3900.0B yen), 38.8% for Operating Income (forecast of 120.0B yen), and 51.6% for Ordinary Income (forecast of 140.0B yen). The Operating Income progress rate was 11.2pt below the standard half-year progress rate of 50%, requiring approximately 73.5B yen of Operating Income in the second half, equivalent to approximately 1.58 times the first-half amount, to achieve the full-year target. Progress toward the Ordinary Income and Net Income forecasts exceeded standard levels, making recovery of core-business earnings in the second half, excluding the boost from non-operating and extraordinary income, the key focus. The earnings forecast was revised during the current quarter.

Shareholder Returns

The Q2 (interim) dividend was ¥45.00 per share, and the full-year forecast dividend is ¥95.00. Based on forecast EPS of ¥143.52, the forecast Payout Ratio is approximately 66.2%, while the Payout Ratio based on disclosed actual results (calculated from interim Net Income) is approximately 62.0%. As the actual amount of share repurchases was not included in the disclosed data, the Total Return Ratio including share repurchases has not been calculated. The financial base of 68.09B yen in cash and deposits and an Equity Ratio of 70.1% supports dividend payments; however, as full-year Operating Income progress stands at only 38.8%, recovery of core-business earnings in the second half will affect the securing of funds for dividends.

Risk Factors

1. Profitability of domestic businesses: The Dairy Business continues to report an operating loss of 41.7B yen, while the Health & Food Business continues to report a loss of 14.4B yen. Combined revenue from the two businesses was 53.37B yen, representing 29.6% of consolidated revenue, and delays in improving the domestic earnings structure could offset the earnings contribution from growth in the Overseas Business.

2. Dependence on a short-term funding structure: Of interest-bearing debt of 17.25B yen, 17.14B yen (approximately 99.4%) consisted of short-term borrowings, resulting in a concentration of maturities in the short term. Cash and deposits of 68.09B yen were approximately 3.97 times short-term borrowings, ensuring liquidity; however, refinancing terms will require monitoring if the funding environment changes.

3. Rising dependence on the Overseas Business: The Overseas Business accounted for 30.0% of revenue and was the largest earnings driver, with segment income of 75.8B yen against consolidated Operating Income of 46.5B yen (the consolidated figure after offsetting losses from domestic businesses). Dependence on specific regions and foreign exchange fluctuations is increasing, and a slowdown in this business could significantly affect consolidated earnings.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (food_beverage)

Profitability and Returns

Both the operating margin and net profit margin are considered to be at the lower end compared with general levels in the food and beverage industry.

Growth and Capital Efficiency

The revenue growth rate is considered to be at a reasonable level, driven by growth in the Overseas Business.

Source: Compiled by the Company

Key Takeaways from the Earnings Results

1. While high growth and high profitability in the Overseas Business (margin of 14.0%, an improvement equivalent to +280bp YoY) are the primary drivers of consolidated performance, the polarization of the domestic and overseas earnings structure is clear, with continued losses in the Dairy and Health & Food Businesses.

2. The Operating Income progress rate of 38.8% is below the standard half-year progress rate of 50% required to achieve the full-year forecast, making the need for Operating Income in the second half of approximately 1.58 times the first-half amount a key point to monitor in assessing full-year performance.

3. Ordinary Income and Net Income include contributions from non-recurring factors such as non-operating income and gains on the sale of investment securities. The divergence from the core-business operating margin of 2.6% is an important observation point when assessing earnings quality.

Theoretical Share Price (Reference Value)

Sensitivity: ¥3,626–¥3,831 at ±1% for the cost of equity, and ¥3,704–¥3,740 at ±0.1 for ω.

Notes:

• As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used (there is a timing gap relative to the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated from publicly disclosed data only; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting experts as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q2 performance was a clear year-on-year earnings recovery, led by international operations, although group profitability and capital efficiency remain subdued. Revenue increased 9.7% YoY to ¥180.4bn. Operating income rose 42.8% YoY to ¥4.65bn. Profit attributable to owners increased 32.8% YoY to ¥4.97bn. The operating margin expanded 60bp YoY to 2.6% from 2.0%. Gross margin nevertheless contracted by approximately 90bp YoY to 37.1%, indicating that cost-of-sales pressure persisted despite top-line growth. SG&A as a percentage of sales declined by approximately 150bp to 34.5%, more than offsetting the gross-margin decline and creating the operating-profit improvement. Overseas business was the principal earnings driver, with revenue rising 32.3% to ¥54.1bn and segment profit increasing 66.1% to ¥7.58bn. Overseas segment profit exceeded consolidated operating income because several domestic segments remained loss-making or delivered lower profits. The dairy business reported a ¥4.17bn segment loss, widening from a ¥3.75bn loss in the prior-year period. Health and food also remained loss-making, albeit its loss narrowed to ¥1.44bn from ¥1.68bn. Ordinary income of ¥7.22bn exceeded operating income by ¥2.57bn, supported by non-operating income including subsidy income, dividends, interest income and foreign-exchange gains. Pre-tax income also included a net extraordinary gain, principally a ¥5.01bn gain on sale of investment securities. The effective tax rate was relatively high at 35.5%, reducing the conversion of pre-tax profit to net income. The balance sheet remains conservatively capitalized, with a 69.9% capital adequacy ratio and interest-bearing debt equal to only 6.0% of capital. However, the sharp increase in short-term borrowings and treasury stock warrants attention as a capital-allocation and refinancing consideration. Full-year guidance implies a second-half operating-income acceleration, since Q2 operating-income progress is only 38.8% against the annual forecast. The revised forecast and continued overseas momentum are constructive, but delivery depends on restoring domestic profitability while protecting margins against food-input, packaging, energy and foreign-exchange volatility.

Profitability Analysis

Annualized DuPont ROE is 3.7%, comprising a 2.8% net profit margin, 0.933x asset turnover and 1.43x financial leverage. The primary constraint is profitability rather than leverage: financial leverage is modest and asset turnover is reasonable for an asset-backed food manufacturer, while the net margin remains below the 3% concern threshold. Annualized ROIC of 2.7% similarly indicates that operating returns on invested capital remain low. EBIT margin was 2.6%, triggering the low-operating-efficiency alert and remaining below the 5% minimum benchmark despite the 60bp YoY improvement. The improvement was driven by operating leverage, as revenue grew 9.7% while SG&A rose 5.5%; SG&A therefore declined to 34.5% of revenue from 36.0%. Gross margin declined to 37.1% from approximately 38.0%, a contraction of about 90bp, demonstrating that the earnings recovery has not yet resolved underlying cost pressure. Advertising and promotion expense declined 2.8% YoY to ¥7.16bn, while salaries and allowances increased 8.7% to ¥12.51bn. The largest positive segment contribution came from Overseas, where segment margin rose to 14.0% from 11.2%. Food ingredients improved segment margin to 19.5% from 15.5% despite a 1.6% revenue decline, suggesting better mix or cost control. Conversely, dairy segment margin worsened to negative 13.0% from negative 12.2%, and nutrition confectionery profit fell 51.2% despite broadly flat revenue. The 5-factor profile shows a 0.641 tax burden and an interest burden above 1.0 because non-operating income exceeds interest cost; interest coverage of 51.71x confirms that financing cost is not currently constraining earnings. JGAAP goodwill is immaterial at ¥1.12bn, or 0.4% of equity, so goodwill amortization and impairment risk are not material distortions of operating profitability.

Growth Assessment

Revenue growth was broad but uneven across the portfolio. Overseas revenue increased ¥13.21bn YoY, accounting for roughly 84% of the group’s ¥15.87bn revenue increase, and its share of consolidated sales rose to 30.0% from 24.8%. Domestic Other revenue increased 2.1% to ¥36.7bn, dairy increased 4.9% to ¥32.2bn, health and food increased 2.1% to ¥21.2bn, and nutrition confectionery was essentially flat at ¥29.9bn. Food ingredients revenue declined 1.6% to ¥6.27bn. The concentration of incremental profit in Overseas makes continued international demand, local execution and currency conditions central to the growth outlook. Full-year revenue guidance is ¥390.0bn, and Q2 progress is 46.2%, 3.8 percentage points below the standard 50% first-half pace. Full-year operating-income guidance is ¥12.0bn, for which Q2 progress is 38.8%, 11.2 percentage points below the standard pace and therefore requires a stronger second half. Ordinary-income progress is 51.6% against the ¥14.0bn forecast, while profit attributable to owners has reached 55.3% of the ¥9.0bn forecast. This divergence indicates that management’s full-year operating target depends less on non-operating support and more on a recovery in core profitability. The forecast calls for 7.9% revenue growth and 37.4% operating-income growth for the full year, consistent with further margin expansion but leaving limited room for renewed domestic losses or input-cost inflation. For a branded food company, the 37.1% gross margin remains within the healthy 25-40% industry range, but the recent decline highlights the importance of pricing power, product mix and procurement discipline.

Financial Health

Liquidity is solid, with a current ratio of 181.5%, a quick ratio of 156.1%, and working capital of ¥77.39bn. Cash and deposits of ¥68.09bn cover short-term loans of ¥17.14bn by 3.97x. Interest-bearing debt totals ¥17.25bn, equivalent to 6.0% of capital, while the reported debt-to-equity ratio is 0.43x; neither indicates excessive balance-sheet leverage. Interest coverage of 51.71x further supports strong debt-service capacity. There is no current-ratio warning and no D/E warning under the stated thresholds. The material financial-health issue is maturity concentration: 99.4% of interest-bearing debt is short term, which triggers the refinancing-risk alert. Short-term loans increased from ¥0.05bn to ¥17.14bn YoY, while long-term loans were stable at only ¥0.11bn. This is not a near-term liquidity stress given cash coverage and positive working capital, but it increases dependence on rolling short-term facilities and should be assessed alongside the company’s funding purpose and capital-return activity. Total equity declined ¥76.78bn YoY to ¥270.85bn despite interim comprehensive income of ¥8.90bn, with treasury stock increasing by ¥13.38bn and equity also affected by balance-sheet valuation movements. Investment securities increased ¥56.57bn YoY to ¥61.48bn, representing 15.9% of total assets; this creates sensitivity of equity and comprehensive income to market valuations. Deferred tax liabilities were ¥12.96bn, principally relevant to the substantial investment-security and other valuation reserve base. Goodwill, at only 0.3% of assets, does not create meaningful acquisition-related solvency or impairment risk.

Notable B/S Changes

Short-term loans: +¥17.10bn YoY to ¥17.14bn (+37,167%) - funding shifted materially toward short-term borrowings; cash coverage is strong, but the 99.4% short-term debt ratio creates rollover exposure. Treasury stock: increased by ¥13.38bn YoY to negative ¥26.98bn (-98.3%) - substantial treasury-share accumulation reduced equity and raises the importance of monitoring total shareholder returns. Investment securities: +¥5.66bn YoY to ¥61.48bn (+10.1%) - the absolute increase exceeds ¥5.0bn and reinforces exposure of equity and OCI to security-market valuation changes. Accounts payable: -¥9.82bn YoY to ¥34.45bn (-22.2%) - lower supplier financing coincided with higher short-term borrowings and should be monitored within the overall working-capital funding structure. Total assets: -¥7.51bn YoY to ¥386.62bn (-1.9%) and total equity: -¥7.68bn YoY to ¥270.85bn (-2.8%) - the balance sheet remained large and strongly capitalized, but equity declined despite positive interim comprehensive income.

Cash Flow Quality

Dividend Sustainability

The interim dividend is ¥45 per share, unchanged from the prior-year interim payment. Based on interim EPS of ¥79.32, the calculated Q2 dividend payout ratio is 62.0%. The full-year dividend forecast is ¥95 per share, implying an estimated full-year dividend payout ratio of approximately 66.2% based on forecast EPS of ¥143.52. This is moderately above the 60% sustainability benchmark, but it remains below a level that would by itself signal an earnings-coverage warning. Retained earnings of ¥230.04bn and net cash of approximately ¥50.84bn after deducting interest-bearing debt provide substantial balance-sheet support for the dividend. Treasury stock rose by ¥13.38bn YoY to negative ¥26.98bn, indicating meaningful share repurchase or other treasury-share acquisition activity; dividends plus buybacks should therefore be evaluated as a total return ratio rather than through the dividend payout ratio alone. Maintaining the ¥95 annual dividend is more credible if the company achieves the required second-half improvement in operating income and contains losses in dairy and health/food businesses.

Risk Assessment

Business risks include Overseas operations generated roughly 84% of consolidated revenue growth and ¥7.58bn of segment profit; a slowdown in overseas demand, unfavorable local competition, execution issues or currency volatility would have an outsized impact on the earnings recovery., Dairy reported a ¥4.17bn segment loss, worsening ¥0.42bn YoY, while health and food remained loss-making at ¥1.44bn. Persistent domestic losses could absorb the earnings contribution from overseas operations., Food-input, packaging and energy-cost inflation remains a material industry risk, as evidenced by the approximately 90bp gross-margin contraction despite higher sales., Food safety incidents, quality-control failures, product recalls, labeling regulation and shifts toward private-label products could impair brand value and retailer relationships..

Financial risks include The 99.4% short-term debt ratio is a refinancing-risk alert. Although cash covers short-term debt 3.97x, the funding structure is concentrated in borrowings that require rollover., Investment securities of ¥61.48bn, or 15.9% of assets, expose equity and comprehensive income to market-value movements., Treasury stock nearly doubled to ¥26.98bn, reducing equity and potentially elevating total shareholder distributions relative to recurring earnings if buybacks continue..

Key concerns include Low operating efficiency is the most important fundamental issue: EBIT margin is 2.6% and annualized ROIC is 2.7%, both below 5% benchmark levels., The full-year operating-income forecast requires second-half outperformance because first-half progress is 38.8%, 11.2 percentage points below the standard 50% pace., The ¥5.01bn gain on sale of investment securities supported pre-tax profit and is non-recurring, so net-income momentum should not be extrapolated solely from the reported first-half result., The 35.5% effective tax rate limited earnings conversion and remains relevant to the gap between ¥7.76bn pre-tax income and ¥4.97bn profit attributable to owners..

Investment Implications

Key takeaways include The first-half recovery is genuine at the operating level, with operating income up 42.8% and margin up 60bp YoY., Overseas is the core business by operating-income contribution and the decisive source of group growth and profit expansion., Domestic portfolio profitability remains mixed, with widening dairy losses and sharply lower nutrition-confectionery profit offsetting improvements elsewhere., The balance sheet is liquid and lightly levered, but the abrupt shift toward short-term borrowing and larger treasury stock merits monitoring., Reported net income includes non-recurring securities-sale gains, so operating-income delivery is the more relevant measure of recurring progress..

Metrics to watch include Overseas revenue growth and segment margin, currently 32.3% YoY growth and a 14.0% margin, Dairy segment loss, currently negative ¥4.17bn, Consolidated gross margin, currently 37.1%, Second-half operating-income delivery versus ¥12.0bn full-year guidance, Short-term loans and the short-term debt ratio, currently ¥17.14bn and 99.4%, Total shareholder returns, including changes in treasury stock, Investment-securities valuation and associated OCI movements.

Regarding relative positioning, Glico combines a strong liquidity profile, high capital adequacy and a healthy branded-food gross margin with below-benchmark operating margin, ROE and ROIC. Relative earnings quality is improving through SG&A leverage and overseas scale, but the company remains operationally less efficient than a mature high-return consumer-staples profile until domestic loss-making businesses normalize and the operating margin sustains a level above 5%.